相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
Jennifer M. Logue et al.
HAEMATOLOGICA (2021)
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma
Paolo Strati et al.
HAEMATOLOGICA (2021)
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
M-L Schubert et al.
ANNALS OF ONCOLOGY (2021)
Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies
Takayuki Ikezoe
INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies
Sarah J. Nagle et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
Ana Cordeiro et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?
Robert David Sandler et al.
BONE MARROW TRANSPLANTATION (2020)
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myeloma
Quande Lin et al.
BONE MARROW TRANSPLANTATION (2020)
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies
Ying Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults
Rehab M. Alblooshi et al.
BONE MARROW TRANSPLANTATION (2020)
Circulating intranuclear proteins may play a role in development of disseminated intravascular coagulation in individuals with acute leukemia
Kayo Harada-Shirado et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
Norris Lam et al.
NATURE COMMUNICATIONS (2020)
Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia
Shuangyou Liu et al.
BLOOD CANCER JOURNAL (2020)
DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers
Sripathi M. Sureban et al.
CANCERS (2020)
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Maria-Luisa Schubert et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor-T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma
Jun-Xia Cao et al.
CYTOTHERAPY (2020)
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
Robert David Sandler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
Leila Jafarzadeh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer
Ching-Yao Yang et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies
Craig W. Freyer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
The chimeric antigen receptor -intensive care unit (CAR -ICU) initiative: Surveying intensive care unit practices in the management of CAR T -cell associated toxicities
Cristina Gutierrez et al.
JOURNAL OF CRITICAL CARE (2020)
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
Hua Jiang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment
Stuart J. Carter et al.
RHEUMATOLOGY (2019)
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
Hua Jiang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
Philipp Karschnia et al.
BLOOD (2019)
Early and late hematologic toxicity following CD19 CAR-T cells
Shalev Fried et al.
BONE MARROW TRANSPLANTATION (2019)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
Bing-Lan Zhang et al.
HUMAN GENE THERAPY (2019)
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
Mohit Sachdeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Jiang Lv et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
Emma J. M. Grigor et al.
TRANSFUSION MEDICINE REVIEWS (2019)
Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy
Huiwen Jiang et al.
ANNALS OF HEMATOLOGY (2019)
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Paul La Rosee et al.
BLOOD (2019)
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Ankit J. Kansagra et al.
BONE MARROW TRANSPLANTATION (2019)
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma
Ying Liu et al.
JOURNAL OF IMMUNOLOGY (2019)
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
Xiuqi Wu et al.
MOLECULAR THERAPY (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
leExploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma
Jie Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report
Osamu Honjo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Updates on CAR T-cell therapy in B-cell malignancies
Elad Jacoby et al.
IMMUNOLOGICAL REVIEWS (2019)
Understanding tumor lysis syndrome
Lara Zafrani et al.
INTENSIVE CARE MEDICINE (2019)
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
Mahboubeh Yazdanifar et al.
CELLS (2019)
Chimeric antigen receptor modified T cell (CAR-T) co-expressed with ICOSL-41BB promote CAR-T proliferation and tumor rejection
Wei Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
Kevin J. Curran et al.
BLOOD (2019)
Tumor Lysis Syndrome
Shelly M. Williams et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Ren-Yu Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report
Xia Xiao et al.
CLINICAL CANCER RESEARCH (2019)
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
Rebecca A. Gardner et al.
BLOOD (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo
Yanjing Song et al.
PROTEIN & CELL (2018)
Extracellular histones activate autophagy and apoptosis via mTOR signaling in human endothelial cells
Jose Santiago Ibanez-Cabellos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
Jae H. Park et al.
CLINICAL INFECTIOUS DISEASES (2018)
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome
Giusi Prencipe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Interleukin-6: designing specific therapeutics for a complex cytokine
Christoph Garbers et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer
Minsung Kim et al.
PLOS ONE (2018)
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
Hui Shi et al.
JOURNAL OF THORACIC DISEASE (2018)
Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis
Rebecca A. Marsh
FRONTIERS IN IMMUNOLOGY (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
Kelong Tao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review
Lingdi Zhao et al.
IMMUNOTHERAPY (2018)
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy
Erhao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
Joshua A. Hill et al.
BLOOD (2018)
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Claudia Bracaglia et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Driving gene-engineered T cell immunotherapy of cancer
Laura A. Johnson et al.
CELL RESEARCH (2017)
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Sylvia Heink et al.
NATURE IMMUNOLOGY (2017)
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
D. Sommermeyer et al.
LEUKEMIA (2017)
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers
Chengcheng Zhang et al.
MOLECULAR THERAPY (2017)
Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
Leah Alabanza et al.
MOLECULAR THERAPY (2017)
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Frederick L. Locke et al.
MOLECULAR THERAPY (2017)
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome
Claudia Bracaglia et al.
PEDIATRIC RHEUMATOLOGY (2017)
CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
Markus Chmielewski et al.
CELL REPORTS (2017)
Anti-GPEC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenogratfts of Hepatocelluar Carcinoma
Zhiwu Jiang et al.
FRONTIERS IN IMMUNOLOGY (2017)
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
Vita Golubovskaya et al.
CANCERS (2017)
Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights
Amrom E. Obstfeld et al.
BLOOD (2017)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
Mechanisms and risk factors of thrombosis in cancer
Anna Falange et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
A Consensus Review on Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults
Naval Daver et al.
CANCER (2017)
Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy
Eric J. Vick et al.
BLOOD ADVANCES (2017)
Circulating Extracellular Histones Are Clinically Relevant Mediators of Multiple Organ Injury
Chihiro Kawai et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Yongxian Hu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Extracellular histones reduce survival and angiogenic responses of late outgrowth progenitor and mature endothelial cells
H. A. Mena et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Tissue factor as a link between inflammation and coagulation
Marco Witkowski et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2016)
Circulating histones are major mediators of systemic inflammation and cellular injury in patients with acute liver failure
Zongmei Wen et al.
CELL DEATH & DISEASE (2016)
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
Michael S. Magee et al.
ONCOIMMUNOLOGY (2016)
Engineered T cells: the promise and challenges of cancer immunotherapy
Andrew D. Fesnak et al.
NATURE REVIEWS CANCER (2016)
Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology
Gail L. Jones et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature
Stefan K. Alig et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Tumor Lysis Syndrome: New Challenges and Recent Advances
F. Perry Wilson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells
Yao Wang et al.
CLINICAL IMMUNOLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
DeepakBabu Chellapandian et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
Michael Kalos et al.
IMMUNITY (2013)
PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Victor D. Fedorov et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
Marcela V. Maus et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
T Cells That Target Carcinoembryonic Antigen Eradicate Orthotopic Pancreatic Carcinomas Without Inducing Autoimmune Colitis in Mice
Markus Chmielewski et al.
GASTROENTEROLOGY (2012)
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
Kevin J. Curran et al.
JOURNAL OF GENE MEDICINE (2012)
Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4
Fabrizio Semeraro et al.
BLOOD (2011)
Approach to Hemophagocytic Syndromes
Sheila Weitzman
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Ferritin Functions as a Proinflammatory Cytokine via Iron-Independent Protein Kinase C Zeta/Nuclear Factor KappaB-Regulated Signaling in Rat Hepatic Stellate Cells
Richard G. Ruddell et al.
HEPATOLOGY (2009)
Severe Neurologic Side Effects in Patients Being Treated for Hemophagocytic Lymphohistiocytosis
Patrick A. Thompson et al.
PEDIATRIC BLOOD & CANCER (2009)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats
T. Ito et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
分享论文
